Literature DB >> 22318744

Counting the cost of cancer surgery for advanced and metastatic disease.

R C G Russell1, T Treasure.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22318744     DOI: 10.1002/bjs.8695

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


× No keyword cloud information.
  4 in total

1.  If no difference in effectiveness is found between two treatments it may be because the treatments are similarly ineffective.

Authors:  Tom Treasure; Fergus Macbeth; Christopher Russell
Journal:  Ann Transl Med       Date:  2015-08

2.  Survival benefit of palliative gastrectomy in gastric cancer patients with peritoneal metastasis.

Authors:  Masanori Tokunaga; Masanori Terashima; Yutaka Tanizawa; Etsuro Bando; Taiichi Kawamura; Hirofumi Yasui; Narikazu Boku
Journal:  World J Surg       Date:  2012-11       Impact factor: 3.352

3.  Metastatic adenocarcinomas of the stomach or esophagogastric junction (UICC stage IV) are not always a palliative situation: a retrospective analysis.

Authors:  Claus W Schildberg; Thomas Weidinger; Werner Hohenberger; Axel Wein; Melanie Langheinrich; Markus Neurath; Frank Boxberger
Journal:  World J Surg       Date:  2014-02       Impact factor: 3.352

4.  Surgery in the treatment of malignant pleural mesothelioma: recruitment into trials should be the default position.

Authors:  Avijit Datta; Rhiannon Smith; Francesca Fiorentino; Tom Treasure
Journal:  Thorax       Date:  2013-06-12       Impact factor: 9.139

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.